新規登録 | ログイン | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

Vaccine library [517 articles]

最近 Vaccine さんのライブラリ .
  • Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies.
    HIV Clin Trials, Vol. 5, No. 5. (t 2004), pp. 259-268.
    by S Edupuganti, D Weber, C Poole
    posted to no-tag by Vaccine on 2006-03-27 16:38:48 as **
  • Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine.
    Expert Rev Vaccines, Vol. 1, No. 1. (June 2002), pp. 65-74.
    by GT Ray
    posted to no-tag by Vaccine on 2006-03-22 19:08:18 as **
  • AIDS Vaccine 2003. 18-21 September 2003, New York, NY, USA.
    IDrugs, Vol. 6, No. 11. (November 2003), pp. 1046-1048.
    by B Korber
    posted to no-tag by Vaccine on 2006-03-21 14:45:08 as **
  • Immune responses and HIV: a little order from the chaos.
    J Exp Med (13 March 2006)
    by David H H O'connor, Dennis R R Burton
    posted to no-tag by Vaccine on 2006-03-16 17:45:10 as ** along with 1 person Natasha
  • Lymphocyte subset reference ranges in adult Caucasians.
    Clin Immunol Immunopathol, Vol. 60, No. 2. (August 1991), pp. 190-208.
    by T Reichert, M DeBruyère, V Deneys, T Tötterman, P Lydyard, F Yuksel, H Chapel, D Jewell, L Van Hove, J Linden
    posted to no-tag by Vaccine on 2006-03-08 16:25:53 as **
  • Antivector and antitransgene host responses in gene therapy.
    Curr Opin Mol Ther, Vol. 2, No. 4. (August 2000), pp. 376-382.
    by NR Hackett, SM Kaminsky, D Sondhi, RG Crystal
    posted to no-tag by Vaccine on 2006-03-07 16:35:09 as **
  • Complement fixing antibodies to respiratory viruses in children in Jos, Nigeria.
    J Trop Pediatr, Vol. 41, No. 6. (December 1995), pp. 325-327.
    by G Karaivanova, NE Gomwalk, I Dobrev, HO Okunghae
    posted to no-tag by Vaccine on 2006-03-03 20:44:52 as **
  • The burden of pneumonia in children: an Asian perspective.
    Paediatr Respir Rev, Vol. 6, No. 2. (June 2005), pp. 88-93.
    by V Singh
    posted to no-tag by Vaccine on 2006-03-03 20:40:04 as **
  • The rational design of an AIDS vaccine.
    Cell, Vol. 124, No. 4. (24 February 2006), pp. 677-681.
    by DC Douek, PD Kwong, GJ Nabel
    posted to no-tag by Vaccine on 2006-03-02 20:26:50 as ** along with 1 person lyndallsarkies
  • Simian Immunodeficiency Virus Engrafted with Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Epitopes: Replication, Neutralization, and Survey of HIV-1-Positive Plasma.
    J Virol, Vol. 80, No. 6. (March 2006), pp. 3030-3041.
    by E Yuste, HB Sanford, J Carmody, J Bixby, S Little, MB Zwick, T Greenough, DR Burton, DD Richman, RC Desrosiers, WE Johnson
    posted to no-tag by Vaccine on 2006-03-02 20:23:07 as **
  • Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one.
    Vaccine, Vol. 15, No. 5. (April 1997), pp. 533-540.
    by JL Hurwitz, KF Soike, MY Sangster, A Portner, RE Sealy, DH Dawson, C Coleclough
    posted to no-tag by Vaccine on 2006-02-28 15:33:04 as **
  • A two-year respiratory virus survey in four villages in West Bengal, India.
    Am J Epidemiol, Vol. 92, No. 5. (November 1970), pp. 307-320.
    by W Kloene, FB Bang, SM Chakraborty, MR Cooper, H Kulemann, KV Shah, M Ota
    posted to no-tag by Vaccine on 2006-02-28 15:32:10 as **
  • The etiology of respiratory tract infections in a tropical country.
    Am J Epidemiol, Vol. 97, No. 1. (January 1973), pp. 34-43.
    by LC Olson, U Lexomboon, P Sithisarn, HE Noyes
    posted to no-tag by Vaccine on 2006-02-28 15:31:27 as **
  • Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques.
    AIDS Res Hum Retroviruses, Vol. 21, No. 4. (April 2005), pp. 292-300.
    by J Pamungkas, R De Rose, D Iskandriati, R Noviana, Y Paramastri, CJ Dale, M Shoobridge, CJ Medveczky, IA Ramshaw, S Thomson, SJ Kent
    posted to no-tag by Vaccine on 2006-02-27 17:44:14 as **
  • Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective.
    Soc Sci Med, Vol. 60, No. 6. (March 2005), pp. 1197-1208.
    by C Slack, M Stobie, C Milford, G Lindegger, D Wassenaar, A Strode, C Ijsselmuiden
    posted to no-tag by Vaccine on 2006-02-27 17:36:06 as **
  • Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques.
    Virology, Vol. 333, No. 2. (15 March 2005), pp. 226-238.
    by UM Abdel-Motal, J Gillis, K Manson, M Wyand, D Montefiori, K Stefano-Cole, RC Montelaro, JD Altman, RP Johnson
    posted to no-tag by Vaccine on 2006-02-27 17:32:11 as **
  • Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques.
    Virology, Vol. 334, No. 1. (30 March 2005), pp. 124-133.
    by RR Amara, S Sharma, M Patel, JM Smith, L Chennareddi, JG Herndon, HL Robinson
    posted to no-tag by Vaccine on 2006-02-27 17:25:45 as **
  • Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate.
    Vaccine, Vol. 23, No. 26. (16 May 2005), pp. 3434-3445.
    by BK Chakrabarti, X Ling, ZY Yang, DC Montefiori, A Panet, WP Kong, B Welcher, MK Louder, JR Mascola, GJ Nabel
    posted to no-tag by Vaccine on 2006-02-27 17:18:54 as **
  • Non-replicating viral vector-based AIDS vaccines: interplay between viral vectors and the immune system.
    Curr HIV Res, Vol. 3, No. 2. (April 2005), pp. 157-181.
    by SL Sauter, A Rahman, G Muralidhar
    posted to no-tag by Vaccine on 2006-02-27 16:51:01 as **
  • Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge.
    Vaccine, Vol. 23, No. 31. (1 July 2005), pp. 4036-4047.
    by M Busch, K Abel, J Li, M Piatak, JD Lifson, CJ Miller
    posted to no-tag by Vaccine on 2006-02-27 16:37:55 as **
  • Predicting the Potential Public Health Impact of Disease-Modifying HIV Vaccines in South Africa: The Problem of Subtypes.
    Curr Drug Targets Infect Disord, Vol. 5, No. 2. (July 2005), pp. 179-192.
    by SM Blower, EN Bodine, K Grovit-Ferbas
    posted to no-tag by Vaccine on 2006-02-27 16:24:42 as **
  • Motivations for Participating in an HIV Vaccine Efficacy Trial.
    J Acquir Immune Defic Syndr, Vol. 39, No. 3. (1 July 2005), pp. 359-364.
    by Grant Colfax, Susan Buchbinder, Goli Vamshidar, Connie Celum, David McKirnan, Judith Neidig, Beryl Koblin, Marc Gurwith, Brad Bartholow
    posted to no-tag by Vaccine on 2006-02-27 16:21:13 as **
  • Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Vaccine, Vol. 23, No. 42. (10 October 2005), pp. 5009-5021.
    by SJ Kent, CJ Dale, C Ranasinghe, I Stratov, R De Rose, S Chea, DC Montefiori, S Thomson, IA Ramshaw, BE Coupar, DB Boyle, M Law, KM Wilson, AJ Ramsay
    posted to no-tag by Vaccine on 2006-02-27 16:18:07 as **
  • HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake.
    AIDS Educ Prev, Vol. 17, No. 3. (June 2005), pp. 253-267.
    by ET Rudy, PA Newman, N Duan, EM Kelly, KJ Roberts, DS Seiden
    posted to no-tag by Vaccine on 2006-02-27 16:16:18 as **
  • Participant retention in clinical trials of candidate HIV vaccines.
    J Acquir Immune Defic Syndr, Vol. 39, No. 4. (1 August 2005), pp. 499-501.
    by G de Bruyn, MG Hudgens, PS Sullivan, AC Duerr
    posted to no-tag by Vaccine on 2006-02-27 16:13:45 as **
  • HIV vaccine design and the neutralizing antibody problem.
    Nat Immunol, Vol. 5, No. 3. (March 2004), pp. 233-236.
    by DR Burton, RC Desrosiers, RW Doms, WC Koff, PD Kwong, JP Moore, GJ Nabel, J Sodroski, IA Wilson, RT Wyatt
    posted to no-tag by Vaccine on 2006-02-27 16:13:26 as ** along with 2 people cpiscitelli magnusc
  • Changes in Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users
    AIDS and Behavior, Vol. 9, No. 3. (September 2005), pp. 301-309.
    by Elizabeth Golub, Lisa Purvis, Marcella Sapun, Mahboobeh Safaeian, Chris Beyrer, David Vlahov, Steffanie Strathdee
    posted to no-tag by Vaccine on 2006-02-27 15:51:55 as **
  • Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.
    Vaccine, Vol. 23, No. 46-47. (16 November 2005), pp. 5306-5320.
    by X Zhan, LN Martin, KS Slobod, C Coleclough, TD Lockey, SA Brown, J Stambas, M Bonsignori, RE Sealy, JL Blanchard, JL Hurwitz
    posted to no-tag by Vaccine on 2006-02-27 15:50:01 as **
  • Issues related to gay and bisexual men's acceptance of a future AIDS vaccine
    International Journal of STD & AIDS, Vol. 16, No. 8. (August 2005), pp. 546-548.
    by Laura F Salazar, David Holtgrave, Richard A Crosby, Paula Frew, John L Peterson
    posted to no-tag by Vaccine on 2006-02-27 15:39:28 as **
  • Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.
    Virology, Vol. 343, No. 2. (20 December 2005), pp. 246-255.
    by RR Amara, C Ibegbu, F Villinger, DC Montefiori, S Sharma, P Nigam, Y Xu, HM McClure, HL Robinson
    posted to no-tag by Vaccine on 2006-02-27 15:29:24 as **
  • Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
    Public Health Rep, Vol. 120, No. 5. (t 2005), pp. 543-548.
    by G Djomand, J Katzman, D di Tommaso, MG Hudgens, GW Counts, BA Koblin, PS Sullivan
    posted to no-tag by Vaccine on 2006-02-27 15:12:41 as **
  • Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.
    J Infect Dis, Vol. 192, No. 12. (15 December 2005), pp. 2129-2133.
    by DC Johnson, EJ McFarland, P Muresan, T Fenton, J McNamara, JS Read, E Hawkins, PL Bouquin, SG Estep, GD Tomaras, CA Vincent, M Rathore, AJ Melvin, S Gurunathan, J Lambert
    posted to no-tag by Vaccine on 2006-02-27 15:09:19 as **
  • Antibody recognition of a carbohydrate epitope: a template for HIV vaccine design.
    Adv Exp Med Biol, Vol. 564 (2005), pp. 7-8.
    by C Scanlan, D Calarese, HK Lee, O Blixt, CH Wong, I Wilson, D Burton, R Dwek, P Rudd
    posted to no-tag by Vaccine on 2006-02-27 14:26:58 as **
  • Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India.
    Vaccine (4 January 2006)
    by Sanjeev Kumar, Priya Aggarwal, Madhu Vajpayee, R M M Pandey, Pradeep Seth
    posted to no-tag by Vaccine on 2006-02-24 15:25:06 as **
  • Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease.
    J Gen Virol, Vol. 87, No. Pt 3. (March 2006), pp. 595-606.
    by A Laurén, R Thorstensson, EM Fenyö
    posted to no-tag by Vaccine on 2006-02-21 20:21:33 as **
  • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells.
    Blood (7 February 2006)
    by Michael R R Betts, Martha C C Nason, Sadie M M West, Stephen C C De Rosa, Stephen A A Migueles, Jonathan Abraham, Michael M M Lederman, Jose M M Benito, Paul A A Goepfert, Mark Connors, Mario Roederer, Richard A A Koup
    posted to no-tag by Vaccine on 2006-02-21 20:19:18 as **
  • Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits.
    Br J Haematol, Vol. 105, No. 1. (April 1999), pp. 117-121.
    by MC Muñoz, R Montes, J Hermida, J Orbe, JA Páramo, E Rocha
    posted to no-tag by Vaccine on 2006-02-13 14:08:16 as **
  • The regulation of DNA vaccines.
    Curr Opin Biotechnol, Vol. 12, No. 3. (June 2001), pp. 299-303.
    by HA Smith, DM Klinman
    posted to no-tag by Vaccine on 2006-02-10 15:08:24 as **
  • DNA vaccines: development, standardization and regulation.
    Intervirology, Vol. 43, No. 4-6. (2000), pp. 331-338.
    by K Cichutek
    posted to no-tag by Vaccine on 2006-02-10 15:03:23 as **
  • Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.
    Hum Gene Ther, Vol. 14, No. 17. (20 November 2003), pp. 1595-1604.
    by TA Smith, N Idamakanti, J Marshall-Neff, ML Rollence, P Wright, M Kaloss, L King, C Mech, L Dinges, WO Iverson, AD Sherer, JE Markovits, RM Lyons, M Kaleko, SC Stevenson
    posted to no-tag by Vaccine on 2006-02-10 14:17:24 as **
  • The Global Impact of Scaling-Up HIV/AIDS Prevention Programs in Low- and Middle-Income Countries.
    Science (2 February 2006)
    by John Stover, Stefano Bertozzi, Juan-Pablo P Gutierrez, Neff Walker, Karen A A Stanecki, Robert Greener, Eleanor Gouws, Catherine Hankins, Geoff P P Garnett, Joshua A A Salomon, J Ties T Boerma, Paul De Lay, Peter D D Ghys
    posted to no-tag by Vaccine on 2006-02-10 14:15:52 as **
  • Selecting stable molecular targets for treatment and prevention of AIDS.
    Genome Inform Ser Workshop Genome Inform, Vol. 16, No. 1. (2005), pp. 254-261.
    by YE Wang, C Zhang, J Berzofsky, C DeLisi
    posted to no-tag by Vaccine on 2006-02-08 18:18:28 as **
  • Premature Induction of an Immunosuppressive Regulatory T Cell Response during Acute Simian Immunodeficiency Virus Infection.
    J Infect Dis, Vol. 193, No. 5. (1 March 2006), pp. 703-712.
    by JD Estes, Q Li, MR Reynolds, S Wietgrefe, L Duan, T Schacker, LJ Picker, DI Watkins, JD Lifson, C Reilly, J Carlis, AT Haase
    posted to no-tag by Vaccine on 2006-02-08 16:57:22 as **
  • HIV-1 receptors and cell tropism.
    Br Med Bull, Vol. 58 (2001), pp. 43-59.
    by PR Clapham, A McKnight
    posted to no-tag by Vaccine on 2006-02-07 15:21:45 as ** along with 1 person lyndallsarkies
  • Long-term CD8+ T cell memory to Sendai virus elicited by DNA vaccination.
    J Gen Virol, Vol. 80 ( Pt 6) (June 1999), pp. 1393-1399.
    by Y Chen, EJ Usherwood, SL Surman, TL Hogg, DL Woodland
    posted to no-tag by Vaccine on 2006-02-07 15:00:50 as **
  • CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Clin Infect Dis, Vol. 42, No. 5. (1 March 2006), pp. 709-715.
    by C Goujard, M Bonarek, L Meyer, F Bonnet, ML Chaix, C Deveau, M Sinet, J Galimand, JF Delfraissy, A Venet, C Rouzioux, P Morlat,
    posted to no-tag by Vaccine on 2006-02-03 20:03:17 as **
  • Injection drug use and HIV/AIDS transmission in China.
    Cell Res, Vol. 15, No. 11-12. (c 2005), pp. 865-869.
    by TX Chu, JA Levy
    posted to no-tag by Vaccine on 2006-01-26 21:28:34 as **
  • Rural-to-Urban Migrants and the HIV Epidemic in China.
    AIDS Behav (19 January 2006), pp. 1-10.
    by Yan Hong, Bonita Stanton, Xiaoming Li, Hongmei Yang, Danhua Lin, Xiaoyi Fang, Jing Wang, Rong Mao
    posted to no-tag by Vaccine on 2006-01-26 21:04:41 as **
  • GP120: Target for Neutralizing HIV-1 Antibodies.
    Annu Rev Immunol (16 January 2006)
    by Ralph Pantophlet, Dennis R R Burton
    posted to no-tag by Vaccine on 2006-01-25 17:03:12 as ** along with 1 person cpiscitelli
  • Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.
    Hum Gene Ther, Vol. 15, No. 5. (May 2004), pp. 421-431.
    by CM Corona Gutierrez, A Tinoco, T Navarro, ML Contreras, RR Cortes, P Calzado, L Reyes, R Posternak, G Morosoli, ML Verde, R Rosales
    posted to no-tag by Vaccine on 2006-01-25 14:35:03 as **
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/user/Vaccine

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.